Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular LymphomaDaniela Drandi, Marco Ladetto, Elona Saraci et al.|Journal of Molecular Diagnostics|2015Cited by 132
High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomibManuela Gambella, Antonio Palumbo, Alberto Rocci et al.|Haematologica|2014Cited by 56
Minimal residual disease after transplantation or lenalidomide-based consolidation in myeloma patients: a prospective analysisStefania Oliva, Paola Omedè, Manuela Gambella et al.|Oncotarget|2016Cited by 36
Improved Igh-Based MRD Detection By Using Droplet Digital PCR: a Comparison With Real Time Quantitative PCR In MCL and MMDaniela Drandi, Marco Ladetto, Lenka Kubiczková et al.|Blood|2013Cited by 2